News
-
-
-
PRESS RELEASE
Biotest prepares launch of its immunoglobulin Yimmugo in the USA, establishing a framework for a strategic billion-dollar distribution agreement with Kedrion
Biotest AG is set to launch its immunoglobulin Yimmugo in the USA with a strategic billion-dollar agreement with Kedrion, following FDA approval. The distribution deal aims to generate over $1 billion in revenue for Biotest -
-
-
-
-
-
-